Paul Kolm

Author PubWeight™ 66.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med 2008 7.75
2 Comparative effectiveness of revascularization strategies. N Engl J Med 2012 5.49
3 Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med 2010 4.87
4 Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failure. Circulation 2005 2.85
5 Predictors of medication self-management skill in a low-literacy population. J Gen Intern Med 2006 2.40
6 An intervention to overcome clinical inertia and improve diabetes mellitus control in a primary care setting: Improving Primary Care of African Americans with Diabetes (IPCAAD) 8. Arch Intern Med 2006 2.37
7 An endocrinologist-supported intervention aimed at providers improves diabetes management in a primary care site: improving primary care of African Americans with diabetes (IPCAAD) 7. Diabetes Care 2005 1.76
8 Diagnosing and managing cutaneous pigmented lesions: primary care physicians versus dermatologists. J Gen Intern Med 2006 1.65
9 Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry. Circulation 2012 1.50
10 Determining the in-hospital cost of bleeding in patients undergoing percutaneous coronary intervention. J Interv Cardiol 2009 1.47
11 The role of head computer tomographic scans on the management of MICU patients with neurological dysfunction. J Intensive Care Med 2009 1.44
12 Many Americans have pre-diabetes and should be considered for metformin therapy. Diabetes Care 2009 1.43
13 A longitudinal assessment of coronary interventional program quality: a report from the American College of Cardiology-National Cardiovascular Data Registry. JACC Cardiovasc Interv 2009 1.41
14 Left atrial structure and function after percutaneous left atrial appendage transcatheter occlusion (PLAATO): six-month echocardiographic follow-up. J Am Coll Cardiol 2004 1.41
15 Cost-effectiveness of percutaneous coronary intervention in optimally treated stable coronary patients. Circ Cardiovasc Qual Outcomes 2008 1.40
16 Random plasma glucose in serendipitous screening for glucose intolerance: screening for impaired glucose tolerance study 2. J Gen Intern Med 2008 1.28
17 Survival and neurologic recovery in patients with ST-segment elevation myocardial infarction resuscitated from cardiac arrest. J Am Coll Cardiol 2009 1.01
18 Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. J Am Coll Cardiol 2005 1.01
19 Health status and quality of life in patients with stable coronary artery disease and chronic kidney disease treated with optimal medical therapy or percutaneous coronary intervention (post hoc findings from the COURAGE trial). Am J Cardiol 2013 0.92
20 All pre-diabetes is not the same: metabolic and vascular risks of impaired fasting glucose at 100 versus 110 mg/dl: the Screening for Impaired Glucose Tolerance study 1 (SIGT 1). Diabetes Care 2006 0.92
21 Using the AUDIT-PC to predict alcohol withdrawal in hospitalized patients. J Gen Intern Med 2014 0.92
22 Age, BMI, and race are less important than random plasma glucose in identifying risk of glucose intolerance: the Screening for Impaired Glucose Tolerance Study (SIGT 5). Diabetes Care 2008 0.92
23 Use of a uniform treatment algorithm abolishes racial disparities in glycemic control. Diabetes Educ 2008 0.90
24 Patterns of warfarin use and subsequent outcomes in atrial fibrillation in primary care practices. Vasc Health Risk Manag 2012 0.85
25 Cardiopulmonary resuscitation inpatient outcomes in cancer patients in a large community hospital. Del Med J 2012 0.84
26 The cost-effectiveness of percutaneous coronary intervention as a function of angina severity in patients with stable angina. Circ Cardiovasc Qual Outcomes 2011 0.84
27 The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial. Am Heart J 2006 0.84
28 The "metabolic syndrome" is less useful than random plasma glucose to screen for glucose intolerance. Prim Care Diabetes 2008 0.83
29 Emergency department tachypnea predicts transfer to a higher level of care in the first 24 hours after ED admission. Acad Emerg Med 2010 0.83
30 Comparison of recovery after mitral valve repair and replacement. J Thorac Cardiovasc Surg 2007 0.82
31 Use of a glucose algorithm to direct diabetes therapy improves A1C outcomes and defines an approach to assess provider behavior. Diabetes Educ 2006 0.81
32 Cost effectiveness of eplerenone in patients with heart failure after acute myocardial infarction who were taking both ACE inhibitors and beta-blockers: subanalysis of the EPHESUS. Am J Cardiovasc Drugs 2010 0.81
33 Crisis intervention in a military population: a comparison of inpatient hospitalization and a day treatment program. Mil Med 2002 0.80
34 Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trial. Am Heart J 2006 0.80
35 Long-term cost-effectiveness of clopidogrel in STEMI patients. Int J Cardiol 2008 0.79
36 Cost-effectiveness of enoxaparin compared with unfractionated heparin in ST elevation myocardial infarction patients undergoing pharmacological reperfusion: a Canadian analysis of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment - Thrombolysis in Myocardial Infarction (ExTRACT-TIMI) 25 trial. Can J Cardiol 2009 0.79
37 Cost effectiveness of enoxaparin in acute ST-segment elevation myocardial infarction: the ExTRACT-TIMI 25 (Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction 25) study. J Am Coll Cardiol 2009 0.79
38 Reduced 6-month resource use and costs associated with cilostazol in patients after successful coronary stent implantation: results from the Cilostazol for RESTenosis (CREST) trial. Am Heart J 2006 0.79
39 Hip strength in adults with type 1 diabetes is associated with age at onset of diabetes. J Clin Densitom 2011 0.78
40 The risk of cardiovascular events in primary care patients following an episode of severe hypertension. J Clin Hypertens (Greenwich) 2009 0.78
41 Frequency, predictors, and consequences of crossing over to revascularization within 12 months of randomization to optimal medical therapy in the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial. Circ Cardiovasc Qual Outcomes 2013 0.78
42 Methods for the economic and quality of life supplement to the cilostazol for RESTenosis (CREST) trial. J Invasive Cardiol 2004 0.77
43 Frequency of severe valvular disease caused by mediastinal radiation among patients undergoing valve surgery in a community-based, regional academic medical center. Clin Cardiol 2013 0.77
44 Antibiotic prescribing by telephone in primary care. Pharmacoepidemiol Drug Saf 2014 0.77
45 Screening blood donors for diabetes: analysis of use, accuracy, and cost. Transfusion 2013 0.76
46 Effects of surgically induced weight loss by Roux-en-Y gastric bypass on osteocalcin. Surg Obes Relat Dis 2012 0.76
47 Do clinical trials in ischemic heart disease meet the needs of those with ischemia? J Am Coll Cardiol 2015 0.76
48 Digital image analysis: a reliable tool in the quantitative evaluation of cutaneous lesions and beyond. Arch Dermatol 2007 0.75
49 Immediate nipple reconstruction on a free TRAM flap breast reconstruction. Plast Reconstr Surg 2007 0.75
50 Direct care nurses' knowledge in acute myocardial infarction treatment. J Nurses Staff Dev 2012 0.75
51 Cost in the use of enoxaparin compared with unfractionated heparin in patients with atrial fibrillation undergoing a transesophageal echocardiography-guided cardioversion (from Assessment of Cardioversion using Transesophageal Echocardiography [ACUTE] II randomized multicenter study). Am J Cardiol 2008 0.75